
P473: DEVELOPMENT OF POTENTIAL BIOMARKERS FOR IRAK4 INHIBITOR EMAVUSERTIB IN HUMAN ACUTE MYELOID LEUKEMIA
Author(s) -
Ugolkov A.,
Pilichowska M.,
Li C.C.,
Hok R. C.,
Samson M.,
Lane M.,
Von Roemeling R.,
Martell R.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844780.60464.3e
Subject(s) - myeloid leukemia , immunohistochemistry , leukemia , medicine , biomarker , cancer research , refractory (planetary science) , oncology , pathology , biology , biochemistry , astrobiology